Implications Of Following The Guidelines For Genetic Testing And Mri Use For Breast Cancer.

1549 Background: Evidence-based medicine is based upon the use of established guidelines and algorithms to increase the quality and decrease the cost of medical care. Genetic testing for breast cancer gene mutations is offered to women who have a risk ≥ 10% of carrying a mutation or that meet the NCCN Guidelines. Screening with breast magnetic resonance imaging (MRI) is recommended for women who have a lifetime risk ≥ 20% of developing breast cancer. Our purpose is to evaluate the impact of using guideline based care for these medical issues. Methods: With institutional review board approval, we performed a retrospective analysis of data obtained from consecutive women who presented for breast imaging to the Newton Wellesley Hospital Breast Imaging Center from September 3, 2013 to December 31, 2013. Demographic characteristics and breast cancer risk factors were entered into software to evaluate risk (HughesRiskApps) for BRCA mutation, for genetic testing eligibility, for lifetime risk of breast cancer an...